Humira drives AbbVie again
April 28, 2014Sales and Marketing AbbVie, Abbott, Humira, RA
Rheumatoid arthritis treatment Humira has once more driven AbbVie, bringing in more than half the company’s sales in the first …
NICE chair: pharma must show how it prices drugs
April 28, 2014Research and Development, Sales and Marketing Goldacre, Haslam, NICE, VBP, all trials, pars
The pharmaceutical industry must be willing to show the public how it prices its drugs – or face losing its …
Pfizer makes second bid for AstraZeneca
April 28, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, acquisition, deal, merger
Pfizer has made a second attempt to buy AstraZeneca after an initial request was rejected in January. The biggest pharma …
Brazil focus: not just another BRIC in the wall
April 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BRIC, Brazil, emerging markets, market access, rio
Population: 198.7 million (2012) Government: Federal presidential republic Leader: President Dilma Rousseff of the centre-left Workers’ Party Gross Domestic Product: …
reViral hires non-executive director
April 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing reviral, schinazi
Antiviral drug firm reViral has appointed Professor Raymond 
Schinazi as a non-executive director. Schinazi has had a long and prestigious …
Mekinist shown green light by CHMP
April 28, 2014Sales and Marketing CHMP, Cancer, GSK, mekinist, oncology, trametinib
GlaxoSmithKline’s melanoma drug Mekinist is virtually nailed on to be given approval in the European Union following a positive opinion …
Novartis reports healthy profit
April 25, 2014Sales and Marketing Afinitor, Gleevec, Glivec, Novartis, Q1, lilly
Multiple sclerosis drug Gilenya and cancer treatment Afinitor were among the biggest sellers for Novartis, as the Swiss company’s net …
Lupin adds chief corporate development officer
April 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lupin, theresa stevens
Mumbai-based pharma firm Lupin has hired Theresa Stevens to be its chief corporate development officer. Stevens will be assuming …
NHS documentary counts cost
April 25, 2014Medical Communications, Sales and Marketing Channel 4, Drug pricing, NHS, PPRS, vba
The funding issues facing the NHS are to be explored in a new documentary series on Channel 4. Set to …
Profits slump at AstraZeneca
April 24, 2014Sales and Marketing AZD9291, AstraZeneca, BMS, Brilinta, Q1
AstraZeneca has continued its poor run of form, with operating profit in the first quarter of 2014 falling 40% on …
PPD hires Bhooshi De Silva as senior VP


April 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PPD, de silva
Contract research organisation Pharmaceutical Product Development (PPD) has added Bhooshi De Silva as senior VP of corporate development and strategy …
Sovaldi performs for Gilead
April 24, 2014Sales and Marketing Gilead, HCV, Q1, hepatitis C, sovaldi
Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has returned better than expected figures in the first quarter of the …
PrimeVigilance Receives Queen’s Award for Enterprise
April 23, 2014PrimeVigilance Limited (PrimeVigilance), the specialist pharmacovigilance service provider, has been honoured with the Queen’s Award for Enterprise 2014 in the …
Valeant makes $45.7 billion Allergan offer
April 23, 2014Sales and Marketing Allergan, Botox, GSK, Novartis, Pfizer, Valeant, merger, pershing
In the latest proposal in a flurry of merger and acquisition activity in the pharma sector, Valeant Pharmaceuticals International wants …
NICE rejects Kadcyla
April 23, 2014Sales and Marketing CDF, Cancer, Genentech, Kadcyla, NHS, NICE, Roche
NICE has delivered a severe blow to Roche by rejecting its breast cancer ‘smart bomb’ Kadcyla for NHS use in …
Merck Millipore confirms chief executive and president
April 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Millipore, udit batra
Merck Millipore which is the life science division of Merck has named Dr Udit Batra as its incoming president and …
GSK and Novartis sign multi-billion dollar deal
April 23, 2014Research and Development, Sales and Marketing GSK, Novartis, Tafinlar, lilly, merger, tykerb, vaccines
GlaxoSmithKline and Novartis are radically shaking up their businesses, starting up a joint venture while selling off major parts of …
AstraZeneca ‘rejects Pfizer bid’
April 22, 2014Research and Development, Sales and Marketing AstraZeneca, Byetta, Onglyza, Pfizer, Soriot, merger
AstraZeneca has rebuffed a £60 billion bid from Pfizer, according to media reports. Both companies have declined to comment on …
GSK ‘to employ more doctors’
April 22, 2014Medical Communications, Sales and Marketing China, Poland, gsk. doctors, shannon
GlaxoSmithKline is to employ more doctors as members of staff in a bid to ensure that the company is seen …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
